Bioelectronics Corp (BIEL)

[art2426]

I agree and disagree with points in your post. I agree that we as stockholders would not want to see a sale or buyout at this time while we are trading at .0008. That would be the starting price in any negotiations with a buyer, as .0008 is what the market is valuing the company at, right now. Like it or not an offer from buyer starts there. Same scenario if/when the price gets higher as THAT would be the starting figure in negotiations. That is why IMO it is SO important to get the stock price higher for when any talks of sale might happen.

I disagree that .01, at $250 million sale could not happen. With the immense resources that a major player in the pain business has, they will envision so many more clearances they could get for so many more uses these products and PATENTS could provide. The key word is PATENTS. THEY IMO are worth north of 250 mil to one with resources that CAN and will capitalize on all that 'can be accomplished' due to those patents. And due to such financial resources, much faster than we are experiencing now with this cash strapped company.